Company / Operating Margin
Tandem Diabetes Care Operating Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-18.4%
FY2025
5-year range
-31.2% / -1.6%
FY2021-FY2025
Trend
-75.0%
vs FY2024
Sector context
#125 of 148
Health Care
What the data says
Tandem Diabetes Care's operating margin of -18.4% is lower than 84% of companies in the Health Care sector (FY2025). Operating Margin has fluctuated over the past 10 years, ranging from -94.7% in FY2017 to -1.6% in FY2022.
Based on SEC 10-K filings.
-18.4% in FY2025 with a 5-year CAGR of +5.8%.
Improved from -31.2% to -18.4% over the past 2 years.
Health Care sector context is included.
Operating Margin over time
Growth rates
- 3-Year Change
- -16.8pp
- 5-Year Change
- +5.8pp
- 10-Year Change
- -
Sector benchmark
Bottom 16% in Health CareTop 84% of 148This company -18.4% Sector average -284.8%
▼
+93.5% above sector average
Key checks
Key Insights
- In FY2025, operating margin decreased 75.0% year-over-year.
- Currently 266.3pp above the Health Care sector average.
- Peak operating margin was recorded in FY2022.
- Lowest operating margin in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -0.32 (distress zone, below 1.8 threshold)
- Negative profit margin: -20.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -18.4% | -75.0% |
| FY2024 | -10.5% | +66.2% |
| FY2023 | -31.2% | -1849.4% |
| FY2022 | -1.6% | +65.4% |
| FY2021 | -4.6% | +81.0% |
| FY2020 | -24.3% | +58.5% |
| FY2019 | -58.5% | +36.9% |
| FY2018 | -92.6% | +2.2% |
| FY2017 | -94.7% | -2.2% |
| FY2016 | -92.6% | +2.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026